PRA GROUP INC (PRAA): debt financing — PRA Group subsidiary issues €300M of 6.250% Senior Notes due 2032 to repay revolver borrowings

PRA GROUP INC

Issued €300M aggregate principal of 6.250% Senior Notes due September 30, 2032.
Net proceeds to repay ~$174M each from North American and European revolving credit facilities.
Notes are senior unsecured, guaranteed by PRA Group and its domestic restricted subsidiaries.
Optional redemption at make-whole prior to Sep 30, 2028, then step-down premiums from 103.125% to 100%.
Change of control repurchase at 101% of principal; asset sale offer at 100%.

Key facts

Extracted from this filing and checked against the source text.

Debt Financings SEC 8-K Item 2.03/2.04 confidence 0.9

PRA GROUP INC incurred senior notes of €300 million aggregate principal amount with U.S. Bank Trustees Limited at 6.250% per annum maturing September 30, 2032.

Instrument: senior notes
Principal: €300 million aggregate principal amount
Counterparty: U.S. Bank Trustees Limited
Rate: 6.250% per annum
Maturity: September 30, 2032
Event: incurrence

Exact text from the filing

On September 30, 2025, PRA Group Europe Holding II S.à r.l., a private limited liability company ( société à responsabilité limitée ) incorporated and existing under the laws of the Grand Duchy of Luxembourg (the “Issuer”) and a wholly-owned subsidiary of PRA Group, Inc. (the “Company”), completed its previously announced offering of €300 million aggregate principal amount of 6.250% Senior Notes due 2032 (the “Notes”) in a private transaction that was exempt from the registration requirements of the Securities Act of 1933, as amended (the “Securities Act”).

View on SEC.gov

Browse all debt financings →

PRA GROUP INC filing history →

Source: SEC EDGAR

accession 0001185348-25-000034

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.